Skip to main content

Table 3 The risk factors for sarcopenia based on logistic regression

From: Red blood cell distribution width is associated with sarcopenia risk in early-stage non-small cell lung cancer

Variables

COR (95% CI)

p-value

AOR (95% CI)

p-value

Age (>60 vs ≤60 years)

1.624 (1.063 – 2.483)

0.025

1.646 (1.059 – 2.557)

0.027

Gender (male vs female)

0.865 (0.568 – 1.318)

0.499

  

BMI (≥24.0 vs <24.0 kg/m2)

0.571 (0.373 – 0.873)

0.010

0.551 (0.355 – 0.855)

0.008

Smoker (yes vs no)

1.078 (0.675 – 1.720)

0.754

  

Drinker (yes vs no)

1.039 (0.650 – 1.663)

0.872

  

Hypertension (yes vs no)

0.848 (0.497 – 1.447)

0.546

  

Diabetes (yes vs no)

0.896 (0.471 – 1.705)

0.737

  

Comorbidities (yes vs no)

0.670 (0.439 – 1.023)

0.063

  

Histological type (AD vs SCC)

1.055 (0.593 – 1.875)

0.856

  

Lymph node status (positive vs negative)

0.873 (0.556 – 1.371)

0.556

  

Cancer stage (III vs I+II)

1.119 (0.661 – 1.895)

0.676

  

Hemoglobin (≥110 vs <110 g/dl)

0.419 (0.092 – 1.901)

0.260

  

WBC (≥7.0 vs <7.0 ×109/L)

1.452 (0.935 – 2.255)

0.097

  

Platelet count (≥200 vs <200 ×109/L)

1.316 (0.811 – 2.137)

0.266

  

RDW (≥12.9 vs <12.9 %)

2.574 (1.640 – 4.041)

< 0.001

2.516 (1.591-3.981)

< 0.001

Albumin (≥35 vs < 35 g/L)

0.368 (0.102 – 1.329)

0.127

  
  1. The crude odds ratio (COR) with 95% confidence interval (CI) in univariate analysis and adjusted odds ratio (AOR) with (95% CI) in multivariate analysis were shown for variables with significance
  2. BMI Body mass index, AD Adenocarcinoma, SCC Squamous cell carcinoma, NLR Neutrophil-to-lymphocyte ratio, PLR Platelet-to-lymphocyte ratio, RDW Red blood cell distribution width, PNI Prognostic nutritional index